Localization and axonal transport of immunoreactive cholinergic organelles in rat motor neurons--an immunofluorescent study

Distribution of Rab3a in rat nervous system: comparison with other synaptic vesicle proteins and neuropeptides

In the present study we have investigated the distribution of Rab3a in rat peripheral nervous system and compared it with the distribution of other synaptic vesicle proteins (synaptophysin, synapsin I), neuropeptides (CGRP, SP, NPY) and tyrosine hydroxylase (TH). Rab3a immunoreactivity (-IR) was always colocalized with synaptophysin-IR and synapsin I-IR in nerve terminals of the spinal cord and peripheral nerve endings. In many cases, Rab3a-IR was also present in the same axons and terminals as peptides. In crushed sciatic nerve axons, Rab3a was colocalized, proximal to the crush, with synaptophysin-IR, synapsin I-IR, CGRP-IR, and TH-IR, but only partially co-localized with NPY-IR and SP-IR. In the area distal to the crush, Rab3a-IR was very weakly positive in a few thin axons, while larger amount of synaptophysin, CGRP, NPY and SP immunoreactivities were detected. The subcellular distribution of peptides and Rab3a differed in that peptides were observed mainly in large granular structures, while Rab3a-IR was observed mainly as diffuse, finely granular immunoreactivity, in addition to a few exceptional large granules present in some axons. The results demonstrate that Rab3a is widely distributed in different types of neurons, i.e. motor, sensory, autonomic adrenergic and cholinergic neurons, and colocalized with other synaptic vesicle proteins, suggesting that Rab3a may play an essential role in neuronal function. Furthermore, Rab3a is present in many peptide containing axons and terminals, but with an apparently different subcellular distribution, being affiliated mostly with small synaptic vesicles and only occasionally with large vesicles, that may represent peptide contained vesicles.

Acetylcholine transport, storage, and release

ACh is released from cholinergic nerve terminals under both resting and stimulated conditions. Stimulated release is mediated by exocytosis of synaptic vesicle contents. The structure and function of cholinergic vesicles are becoming known. The concentration of ACh in vesicles is about 100-fold greater than the concentration in the cytoplasm. The AChT exhibits the lowest binding specificity among known ACh-binding proteins. It is driven by efflux of protons pumped into the vesicle by the V-type ATPase. A potent pharmacology of the AChT based on the allosteric VR has been developed. It has promise for clinical applications that include in vivo evaluation of the density of cholinergic innervation in organs based on PET and SPECT. The microscopic kinetics model that has been developed and the very low transport specificity of the vesicular AChT-VR suggest that the transporter has a channel-like or multidrug resistance protein-like structure. The AChT-VR has been shown to be tightly associated with proteoglycan, which is an unexpected macromolecular relationship. Vesamicol and its analogs block evoked release of ACh from cholinergic nerve terminals after a lag period that depends on the rate of release. Recycling quanta of ACh that are sensitive to vesamicol have been identified electrophysiologically, and they constitute a functional correlate of the biochemically identified VP2 synaptic vesicles. The concept of transmitter mobilization, including the observation that the most recently synthesized ACh is the first to be released, has been greatly clarified because of the availability of vesamicol. Differences among different cholinergic nerve terminal types in the sensitivity to vesamicol, the relative amounts of readily and less releasable ACh, and other aspects of the intracellular metabolism of ACh probably are more apparent than real. They easily could arise from differences in the relative rates of competing or sequential steps in the complicated intraterminal metabolism of ACh rather than from fundamental differences among the terminals. Nonquantal release of ACh from motor nerve terminals arises at least in part from the movement of cytoplasmic ACh through the AChT located in the cytoplasmic membrane, and it is blocked by vesamicol. Possibly, the proteoglycan component of the AChT-VR produces long-term residence of the macromolecular complex in the cytoplasmic membrane through interaction with the synaptic matrix. The preponderance of evidence suggests that a significant fraction of what previously, heretofore, had been considered to be nonquantal release from the motor neuron actually is quantal release from the neuron at sites not detected electrophysiologically.(ABSTRACT TRUNCATED AT 400 WORDS)

Quantification of axonally transported material using cytofluorimetric scanning

This paper describes in detail a cytofluorimetric scanning technique used for studying amounts of material axonally transported in antero- and retrograde direction in peripheral nerves. Operating procedures, preparation of tissues and instrumental set-up are described. The basis for quantification of material in a nerve section treated for immunofluorescence is discussed. The reliability of the method has been tested by comparing results with biochemical data. There are several advantages of the technique. (1) Many different substances can be studied in one single nerve segment, thus reducing biological variation and costs. (2) Both morphological data and quantitative figures can be obtained; following scanning the section can be photographed. (3) The method can also be used on studies in the central nervous system and on tissue cultures, since it is possible to scan on single axons or bundles of fibres.

Calcitonin gene-related peptide and chromogranin A: presence and intra-axonal transport in lumbar motor neurons in the rat, a comparison with synaptic vesicle antigens in immunohistochemical studies

The presence and intra-axonal transport of calcitonin gene-related peptide and chromogranin A were investigated in motor neurons belonging to the rat sciatic nerve. Their co-localization with markers of cholinergic organelles (SV2, p38, and synapsin I) was also investigated, using immunofluorescence techniques, including double labelling experiments. It was found that motor perikarya in the lumbar spinal cord contained calcitonin gene-related peptide-like immunoreactivity and chromogranin A-like immunoreactivity, and probably also caligulin-like immunoreactivity, located in the Nissl substance of the cytoplasm. Also, some SV2 (detected by the monoclonal antibody 10H) was present in some motor neuron perikarya, but most often these were devoid of SV2 and p38, as well as of synapsin I-like immunoreactivity. These three antigens were, on the other hand, concentrated in nerve terminals in the entire gray substance of the spinal cord. In the ventral root, after crushing, calcitonin gene-related peptide, chromogranin A, synapsin I, SV2, p38 and caligulin-like immunoreactivity accumulated in thick and medium-sized axons proximal to the crush, while only antisera against SV2 and p38 labelled accumulated material distal to the crush. In the sciatic nerve, the same essential picture was observed as in the ventral root, but here two other nervous components were also present in the normal sciatic nerve, i.e. peripheral branches of the sensory system and axons of the sympathetic system. By various denervation procedures, it was demonstrated that most calcitonin gene-related peptide-like immunoreactivity and almost all chromogranin A-like immunoreactivity, accumulating in thick axons proximally, emanated from the ventral root. Thin and medium-sized axons originated from the sensory and sympathetic systems and contributed to accumulations both proximally and distally to the crush. Synapsin I-like immunoreactive material accumulated only proximal to the crush, while SV2 and p38-like material accumulated bidirectionally in axons of all sizes. In motor endplates of the rat diaphragm and gastrocnemic muscle, no calcitonin gene-related peptide-like material was observed. However, some chromogranin A-like immunoreactivity was present, in addition to large amounts of synapsin I-like, p38-like and SV2-like material, which had a finely granular appearance and was concentrated near the presynaptic membrane of the nerve terminal endfeet, where synaptic vesicles are known to be located.

Intraneuronal distribution of a synaptic vesicle membrane protein: antibody binding sites at axonal membrane compartments and trans-Golgi network and accumulation at nodes of Ranvier

The distribution of a cholinergic synaptic vesicle-specific transmembrane glycoprotein (Buckley and Kelly, 1985, J. Cell Biol. 100, 1284-1294) was investigated in the entire electromotor neuron of Torpedo marmorata using a monoclonal antibody and immunocytochemistry at the light- and electron-microscopical level (immunoperoxidase, colloidal gold). In the nerve, terminal binding of immunogold particles is restricted to synaptic vesicles. In the axon a number of additional membrane compartments like multivesicular bodies, vesiculotubular structures, lamellar bodies and electron-dense granules share the surface located synaptic vesicle-specific transmembrane glycoprotein-epitope. Membranous structures likely to represent the axoplasmic reticulum inside axons and nerve terminals are not labelled. Antibody-binding membrane compartments are accumulated at nodes of Ranvier. In the perikaryon the tubules of the trans-Golgi network as well as multivesicular bodies, lamellar bodies, electron-lucent vesicles, granules with electron-dense core and peroxisomes are labelled. Immunotransfer blots of isolated synaptic vesicles and tissue extracts of electric organ display a 100,000 mol. wt band of broad electrophoretic mobility typical of the synaptic vesicle-specific transmembrane glycoprotein. Extracts of electromotor nerve and electric lobe contain in addition a strong band at 85,000 mol. wt and a few lower molecular weight bands. We suggest that the synaptic vesicle originates directly from the trans-Golgi network. The endoplasmic reticulum is not involved in vesicle formation or retrieval. On retrograde transport the vesicle membrane compartment is likely to fuse with other intra-axonal (endosomal?) organelles.

Axonal transport of the synaptic vesicle monoamine carrier identified by [3H]dihydrotetrabenazine binding in rat sciatic nerve

The monoamine carrier of noradrenergic synaptic vesicles was assayed in the rat sciatic nerve by in vitro binding of [3H]dihydrotetrabenazine. The number of binding sites increased with time on both sides of a ligature, indicating fast anterograde and retrograde axoplasmic transports of comparable amplitude. Anterogradely and retrogradely transported binding sites had similar pharmacological properties, which were characteristic of binding to the monoamine carrier embedded within a lipid bilayer. Contrary to the secreted synaptic vesicle matrix constituents, the intrinsic monoamine carrier assayed by [3H]dihydrotetrabenazine binding is a marker adapted to retrograde transport studies.

The contribution of cholinergic enzymes and acetylcholine from the lumbar sympathetic chain to the rat sciatic nerve

This study was performed to investigate how much of the acetylcholine (ACh), choline acetyltransferase (ChAT) and ACh-esterase (AChE) in the rat sciatic nerve originate from the somatic motor input and from the automatic sympathetic input, respectively. The somatic motor axons to the sciatic nerve were eliminated by surgical transsection of the spinal roots, (rhizotomy) and the autonomic component was removed by surgical resection of the lumbar sympathetic chain bilaterally (sympathectomy). Also combined operations were performed. In intact (non-crushed) sciatic nerve rhizotomy caused a reduction in ACh content by 70%, in ChAT-activity by 55%, and in AChE-activity by 41%. Sympathectomy alone had very little influence on ACh and ChAT, but reduced AChE by 20%. After crushing the nerve 13 hours before sacrifice, all three substances accumulated proximal to the crush region as described previously. When compared to the control group, sympathectomy alone caused a reduction in accumulated amounts of AChE only, while ACh and ChAT accumulations were essentially unchanged. Rhizotomy alone caused a substantial reduction in accumulated amounts of all three substances, but most prominently in ACh and ChAT-amounts. After sympathectomy in combination with rhizotomy ACh-accumulations were very low, and enzyme activities were reduced more than in the group with rhizotomy alone. A certain amount of residual ChAT and AChE was present in the nerve, and the location of this is discussed. The fact that combined sympathectomy and rhizotomy lowered ACh accumulations significantly more than would be expected from the results after either operation alone is commented upon.

A case of midgut carcinoid with breast metastasis and cellular localization of serotonin and substance P

A case of midgut carcinoid with breast metastasis is reported. Hepatic metastases stored large amounts of serotonin as demonstrated by the Falck-Hillarp technique. Immunocytochemically serotonin and substance P, which may co-exist in gut enterochromaffin cells, were demonstrated in separate populations of tumor cells both in the hepatic and mammary neoplasms.